Hepatocyte growth factor prevents advanced glycation end products-induced injury and oxidative stress through a PI3K/Akt-dependent pathway in human endothelial cells

This publication has 23 references indexed in Scilit:

• Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor
  American Journal of Physiology-Cell Physiology, 2007
• Pattern of MAP kinases p44/42 and JNK activation by non-lethal doses of tributyltin in human natural killer cells
  Archives of Toxicology, 2006
• A Novel Function of Plasminogen Activator Inhibitor-1 in Modulation of the AKT Pathway in Wild-type and Plasminogen Activator Inhibitor-1-deficient Endothelial Cells
  Published by Elsevier ,2006
• Advanced glycation endproducts—role in pathology of diabetic complications
  Diabetes Research and Clinical Practice, 2005
• Point of NO Return for Nitrergic Nerves in Diabetes: A New Insight into Diabetic Complications
  Current Pharmaceutical Design, 2004
• Bcl2 retards G1/S cell cycle transition by regulating intracellular ROS
  Blood, 2003
• The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family
  Oncogene, 2003
• Advanced glycation end-products induce apoptosis of bovine retinal pericytes in culture: involvement of diacylglycerol/ceramide production and oxidative stress induction
  Free Radical Biology & Medicine, 2002
• Hepatocyte Growth Factor, but Not Insulin-Like Growth Factor I, Protects Podocytes against Cyclosporin A-Induced Apoptosis
  The American Journal of Pathology, 2001
• AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept
  Published by Oxford University Press (OUP) ,1998